References
- ColapricoACavaCBertoliGBontempiGCastiglioniIIntegrative analysis with Monte Carlo cross-validation reveals miRNAs regulating pathways cross-talk in aggressive breast cancerBiomed Res Int2015201583131426240829
- DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
- HoffmannTKDworackiGTsukihiroTSpontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importanceClin Cancer Res2002882553256212171883
- VashistYKLoosJDedowJGlasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancerAnn Surg Oncol20111841130113820981494
- XiaoYRenYKChengHJWangLLuoSXModified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapyInt J Clin Exp Pathol2015855273528126191228
- Chenyue ZhangCWangHNingZPrognostic nutritional index serves as a predictive marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinomaOnco Targets Ther201696417642327799789
- DengQHeBLiuXPrognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive modelJ Transl Med2015136625885254
- HuangYFengJFLow preoperative lymphocyte to monocyte ratio predicts poor cancer-specific survival in patients with esophageal squamous cell carcinomaOnco Targets Ther2015813714525609981
- FengJFHuangYChenQXA new inflammation index is useful for patients with esophageal squamous cell carcinomaOnco Targets Ther201471811181525336972
- HuangYLiuJSFengJFCombination of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a useful predictor of postoperative survival in patients with esophageal squamous cell carcinomaOnco Targets Ther201361605161224403837
- YingHQDengQWHeBSThe prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patientsMed Oncol2014311230525355641
- SobinLHGospodarowiczMKWittekindCTNM Classification of Malignant Tumours7th edNew York, NYJohn Wiley & Sons2011
- MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
- BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
- HiraharaNMatsubaraTHayashiHTakaiKFujiiYTajimaYImpact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancerEur J Surg Oncol201541101308131526235238
- BhattiIPeacockOLloydGLarvinMHallRIPreoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioAm J Surg2010200219720320122680
- McMillanDCThe systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancerCancer Treat Rev201339553454022995477
- ShimadaHTakiguchiNKainumaOHigh preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancerGastric Cancer201013317017620820986
- ImaiTKoikeKKuboTInterleukin-6 supports human megakaryocytic proliferation and differentiation in vitroBlood1991788196919741912578
- RuscettiFWHematologic effects of interleukin-1 and interleukin-6Curr Opin Hematol1994132102159371284
- OhsugiYRecent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseasesBiol Pharm Bull200730112001200617978466